🇺🇸 FDA
Patent

US 11839594

Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

granted A61KA61K31/047A61K31/135

Quick answer

US patent 11839594 (Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride) held by TONIX PHARMA LIMITED expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TONIX PHARMA LIMITED
Grant date
Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/047, A61K31/135, A61K31/137, A61K31/55